Impact of rosiglitazone meta-analysis on use of glucose-lowering medications

BACKGROUND: In May 2007 Nissen and Wolski reported the results of a meta-analysis showing an association between use of rosiglitazone and increased risk of myocardial infarction (N Engl J Med 2007;356(24):2457–2471). Rosiglitazone is an insulin-sensitizing agent used to control blood glucose levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, Richard L, Carney, Greg, Wright, James M, Bassett, Ken, Sutherland, Jenny, Dormuth, Colin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Medicine Publications, Inc. 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116669/
https://www.ncbi.nlm.nih.gov/pubmed/21686295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116669/
https://www.ncbi.nlm.nih.gov/pubmed/21686295

Ejemplares similares